Harnessing Dietary Tryptophan: Bridging the Gap Between Neurobiology and Psychiatry in Depression Management
Open accessThe DOI matches its Crossref record; 445 of the 458 references it cites were found in a registry or an index, and 13 are not checked yet.
Abstract
Major depressive disorder remains a leading cause of disability worldwide, with conventional antidepressants offering incomplete and often transient relief. Mounting evidence highlights disturbances in tryptophan (Trp) metabolism as a key biological axis linking inflammation, neuroplasticity, and mood regulation. Plant-derived compounds that modulate this pathway, including 5-hydroxytryptophan, isoflavones, berberine, and polyphenols, have emerged as promising candidates for integrative treatment strategies. Yet, despite encouraging preclinical and clinical findings, knowledge gaps persist regarding long-term efficacy, mechanistic specificity, and standardized therapeutic protocols. This narrative review explores how Trp modulators influence central and peripheral mechanisms relevant to depression, from serotonergic synthesis and kynurenine shunting to gut–brain–immune interactions. Evidence from animal models and randomized clinical trials is critically synthesized, with particular attention to outcomes on mood stabilization, anxiety reduction, cognitive function, and sleep regulation. Special emphasis is placed on translational potential, methodological limitations, and the need for harmonized research frameworks. Here we highlight that phytochemical interventions represent a mechanistically informed and biocompatible strategy for advancing depression management. By bridging neurobiology and clinical psychiatry, these insights may pave the way for next-generation therapeutics that integrate dietary, microbiota-targeted, and anti-inflammatory approaches. Broader application of this research could ultimately refine personalized psychiatry, expand therapeutic horizons, and contribute to global mental health resilience.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![Figure 2 Tryptophan (Trp) metabolism through the kynurenine (KYN) pathway: balancing neuroprotection and neurotoxicity in depression. This figure illustrates how immune-mediated activation of the KYN pathway disrupts Trp metabolism, linking inflammation with depression-related neuropathology. The stress hormone cortisol stimulates tryptophan 2,3-dioxygenase (TDO). Pro-inflammatory cytokines [interferon (IFN)-alpha (α), IFN-beta (β), IFN-gamma (γ), tumor necrosis factor alpha (TNF-α)] and lipopolysaccharide (LPS) induce indoleamine 2,3-dioxygenases (IDOs), diverting Trp away from serotonin (5-HT) synthesis toward KYN production. In contrast, anti-inflammatory cytokines [interleukin (IL)-4, IL-10] and superoxide dismutase (SOD) counteract this process. Oxygen molecule (O2), IFN-β, IFN-γ, and TNF-α stimulate and IL-4, IL-10, and SOD suppress kynurenine 3-monooxygenase (KMO). Furthermore, IDOs, TDO, and KMO activities are influenced by positive and negative feedback loops. Peripheral KYN crosses the blood–brain barrier, where it undergoes two competing fates: (i) conversion into kynurenic acid (KYNA), a putative neuroprotective N-Methyl-D-Aspartate (NMDA) receptor antagonist with putative antioxidant properties, or (ii) metabolism into 3-hydroxykynurenine (3-HK) and quinolinic acid (QA), which promotes reactive oxygen species (ROS), NMDA receptor overstimulation, mitochondrial dysfunction, and neuronal apoptosis, ultimately leading to neurodegeneration. The dashed inhibitory arrow indicates that enhanced KYN metabolism reduces 5-HT and melatonin synthesis, impairing neurotransmission and neuroprotection. The balance between KYNA and QA determines whether the KYN pathway promotes resilience or vulnerability to depression. Abbreviations: ↑, Increase.](https://figures.cochat.ai/paper-figures/cc16b0b7ddf143b5864943d377b69c49/harnessing-dietary-tryptophan-bridging-the-gap-between-neurobiology-and-figure-2.jpg)




![Figure 7 Mechanistic actions of phytochemicals in depression. Phytochemicals, including 5-hydroxytryptophan (5-HTP), isoflavones, berberine, and polyphenols, exert central effects through modulation of the gut microbiome (via tryptophan [Trp] metabolism), regulation of immune signaling (attenuation of inflammation), and stimulation of neurogenesis (enhancement of plasticity and mood stabilization), collectively contributing to antidepressant outcomes.](https://figures.cochat.ai/paper-figures/ed95233c9b524d19b071d6bd870bc145/harnessing-dietary-tryptophan-bridging-the-gap-between-neurobiology-and-figure-7.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“At the systems scale, deficits in hippocampal and prefrontal plasticity seen in susceptible strains are reversible when interventions reset both synaptic strength and excitability, whether via pharmacology, experience-dependent enrichment, electroconvulsive therapy, or molecular levers such as SIRT1 that couple intrinsic firing properties to synaptic throughput [12,349,399].”
From Synaptic Plasticity—Intrinsic Excitability and Antidepressant Discovery (2026) · cites this paper as [12]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“With few exceptions, systematic targeting of Kv7, HCN, or GIRK channels in depression has lagged behind synaptic plasticity-based approaches, representing a major and underdeveloped opportunity for antidepressant discovery [12,27,30,31].”
From Synaptic Plasticity—Intrinsic Excitability and Antidepressant Discovery (2026) · cites this paper as [12]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cryan, J. F., O'Riordan, K. J., Cowan, C. S. M., Sandhu, K. V., Bastiaanssen, T. F. S., Boehme, M., Codagnone, M. G., Cussotto, S., Fulling, C., Golubeva, A. V., et al. (2019) · Physiological Reviews · doi:10.1152/physrev.00018.2018 · Cited by 5,286 · cited 3×
“Longitudinal and mechanistic trials are urgently needed to clarify causality and optimize intervention strategies in psychiatric and neurodegenerative disorders [181,188,191].”
Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes
Kwon, H. S., & Koh, S.-H. (2020) · Translational Neurodegeneration · doi:10.1186/s40035-020-00221-2 · Cited by 2,595
Response of Phenylpropanoid Pathway and the Role of Polyphenols in Plants under Abiotic Stress
Sharma, A., Shahzad, B., Rehman, A., Bhardwaj, R., Landi, M., & Zheng, B. (2019) · Molecules · doi:10.3390/molecules24132452 · Cited by 2,038
The blood–brain barrier: Structure, regulation and drug delivery
Wu, D., Chen, Q., Chen, X., Han, F., Chen, Z., & Wang, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01481-w · Cited by 1,906 · cited 1×
“Albiflorin, a bioactive monoterpene glycoside, demonstrates a complementary mode of action: gut microbes metabolize it into benzoic acid, which penetrates the blood–brain barrier and inhibits D-amino acid oxidase, ultimately fostering neurogenesis and reducing depressive symptoms [275,276].”
Sheller, M. J., Edwards, B., Reina, G. A., Martin, J., Pati, S., Kotrotsou, A., Milchenko, M., Xu, W., Marcus, D., Colen, R. R., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-69250-1 · Cited by 1,646 · cited 1×
“Beyond efficacy, safety monitoring on a global scale provides crucial insight into rare adverse events and long-term tolerability [359,360,363].”
Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond
Platten, M., Nollen, E. A. A., Röhrig, U. F., Fallarino, F., & Opitz, C. A. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0016-5 · Cited by 1,586 · cited 1×
“Clinical translation represents the critical step of transforming mechanistic insights and preclinical discoveries into therapeutic strategies that can be safely and effectively applied in patient care [150,347,348].”
Impact of the Gut Microbiota on Intestinal Immunity Mediated by Tryptophan Metabolism
Gao, J., Xu, K., Liu, H., Liu, G., Bai, M., Peng, C., Li, T., & Yin, Y. (2018) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2018.00013 · Cited by 1,298
Major depressive disorder: hypothesis, mechanism, prevention and treatment
Cui, L., Li, S., Wang, S., Wu, X., Liu, Y., Yu, W., Wang, Y., Tang, Y., Xia, M., & Li, B. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01738-y · Cited by 1,244 · cited 3×
“These multitarget, biocompatible candidates warrant rapid, translational exploration to transform MDD management [3,8].”
Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases
Loh, J. S., Mak, W. Q., Tan, L. K. S., Ng, C. X., Chan, H. H., Yeow, S. H., Foo, J. B., Ong, Y. S., How, C. W., & Khaw, K. Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01743-1 · Cited by 1,193
Jacka, F. N., O’Neil, A., Opie, R., Itsiopoulos, C., Cotton, S., Mohebbi, M., Castle, D., Dash, S., Mihalopoulos, C., Chatterton, M. L., et al. (2017) · BMC Medicine · doi:10.1186/s12916-017-0791-y · Cited by 1,093
Tryptophan Metabolism: A Link Between the Gut Microbiota and Brain
Gao, K., Mu, C.-L., Farzi, A., & Zhu, W.-Y. (2020) · Advances in Nutrition · doi:10.1093/advances/nmz127 · Cited by 1,029
Colucci-D’Amato, L., Speranza, L., & Volpicelli, F. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207777 · Cited by 991
Tryptophan metabolism in health and disease
Xue, C., Li, G., Zheng, Q., Gu, X., Shi, Q., Su, Y., Chu, Q., Yuan, X., Bao, Z., Lu, J., et al. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.06.004 · Cited by 961
The serotonin theory of depression: a systematic umbrella review of the evidence
Moncrieff, J., Cooper, R. E., Stockmann, T., Amendola, S., Hengartner, M. P., & Horowitz, M. A. (2023) · Molecular Psychiatry · doi:10.1038/s41380-022-01661-0 · Cited by 960
The Economic Burden of Adults with Major Depressive Disorder in the United States (2010 and 2018)
Greenberg, P. E., Fournier, A.-A., Sisitsky, T., Simes, M., Berman, R., Koenigsberg, S. H., & Kessler, R. C. (2021) · PharmacoEconomics · doi:10.1007/s40273-021-01019-4 · Cited by 838
The gut-brain axis: how microbiota and host inflammasome influence brain physiology and pathology
Rutsch, A., Kantsjö, J. B., & Ronchi, F. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.604179 · Cited by 821
The Semantics of Microglia Activation: Neuroinflammation, Homeostasis, and Stress
Woodburn, S. C., Bollinger, J. L., & Wohleb, E. S. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02309-6 · Cited by 783
Impact of microbiota on central nervous system and neurological diseases: the gut-brain axis
Ma, Q., Xing, C., Long, W., Wang, H. Y., Liu, Q., & Wang, R.-F. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1434-3 · Cited by 748
The blood-brain barrier in aging and neurodegeneration
Knox, E. G., Aburto, M. R., Clarke, G., Cryan, J. F., & O’Driscoll, C. M. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01511-z · Cited by 738 · cited 1×
“Together, the data suggest that berberine and albiflorin represent promising candidates for modulating Trp metabolism, suppressing neuroinflammation, and enhancing cognitive resilience, warranting rigorous clinical validation to confirm their therapeutic potential [279,280].”
Kynurenine pathway metabolism and the microbiota-gut-brain axis
Kennedy, P. J., Cryan, J. F., Dinan, T. G., & Clarke, G. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.07.002 · Cited by 724 · cited 1×
“Prebiotics, by selectively stimulating beneficial gut bacteria, also influence the production of neuroactive metabolites, offering an indirect yet consequential means of modulating the Trp–KYN pathway [31,431,437].”
Microbial tryptophan metabolites regulate gut barrier function via the aryl hydrocarbon receptor
Scott, S. A., Fu, J., & Chang, P. V. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2000047117 · Cited by 696
Diet and depression: Exploring the biological mechanisms of action
Marx, W., Lane, M., Hockey, M., Aslam, H., Berk, M., Walder, K., Borsini, A., Firth, J., Pariante, C. M., Berding, K., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-020-00925-x · Cited by 685
Krishnan, S., Ding, Y., Saedi, N., Choi, M., Sridharan, G. V., Sherr, D. H., Yarmush, M. L., Alaniz, R. C., Jayaraman, A., & Lee, K. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.03.109 · Cited by 679 · cited 1×
“Profiling gut microbiota, serum metabolites, and inflammatory markers allows clinicians to predict and monitor how patients metabolize Trp-rich foods or supplements [427–429].”
Kappelmann, N., Lewis, G., Dantzer, R., Jones, P. B., & Khandaker, G. M. (2018) · Molecular Psychiatry · doi:10.1038/mp.2016.167 · Cited by 659 · cited 1×
“Crucially, immunomodulatory interventions can reverse this profile: ketamine lowers IL-6 and TNF-α in treatment-resistant depression in tandem with rapid affective recovery, and targeted anti-cytokine therapies normalize peripheral markers while lifting mood in case studies and pilot trials [75–77].”
Gut microbiota and its metabolites in depression: from pathogenesis to treatment
Liu, L., Wang, H., Chen, X., Zhang, Y., Zhang, H., & Xie, P. (2023) · eBioMedicine · doi:10.1016/j.ebiom.2023.104527 · Cited by 655
Parletta, N., Zarnowiecki, D., Cho, J., Wilson, A., Bogomolova, S., Villani, A., Itsiopoulos, C., Niyonsenga, T., Blunden, S., Meyer, B., et al. (2019) · Nutritional Neuroscience · doi:10.1080/1028415x.2017.1411320 · Cited by 629
Microglia in depression: an overview of microglia in the pathogenesis and treatment of depression
Wang, H., He, Y., Sun, Z., Ren, S., Liu, M., Wang, G., & Yang, J. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02492-0 · Cited by 571
Firth, J., Marx, W., Dash, S., Carney, R., Teasdale, S. B., Solmi, M., Stubbs, B., Schuch, F. B., Carvalho, A. F., Jacka, F., et al. (2019) · Psychosomatic Medicine · doi:10.1097/psy.0000000000000673 · Cited by 566 · cited 2×
“Emerging evidence shows that personalized diets can reduce depressive symptoms, alter microbial composition, and improve quality of life in both older adults and adolescents [393,399,427].”
Liu, R. T., Walsh, R. F. L., & Sheehan, A. E. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.03.023 · Cited by 564
Zhang, J.-C., Yao, W., & Hashimoto, K. (2016) · Current Neuropharmacology · doi:10.2174/1570159x14666160119094646 · Cited by 538 · cited 2×
“Compounding these injuries, elevations in IL-6 and TNF-α draw down BDNF, a molecule essential for synaptic refinement and mood stability, thereby tightening the grip of inflammation on neuroplasticity [105–107].”
Kazemi, A., Noorbala, A. A., Azam, K., Eskandari, M. H., & Djafarian, K. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2018.04.010 · Cited by 534 · cited 2×
“Probiotics and prebiotics are the most extensively studied, with randomized controlled trials showing that probiotic supplementation can alleviate depressive symptoms, maintain microbial diversity, and enhance serotonergic signaling [386,433,434].”
Blockade of the AHR restricts a Treg-macrophage suppressive axis induced by L-Kynurenine
Campesato, L. F., Budhu, S., Tchaicha, J., Weng, C.-H., Gigoux, M., Cohen, I. J., Redmond, D., Mangarin, L., Pourpe, S., Liu, C., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17750-z · Cited by 516
Molecular pathways of major depressive disorder converge on the synapse
Fries, G. R., Saldana, V. A., Finnstein, J., & Rein, T. (2023) · Molecular Psychiatry · doi:10.1038/s41380-022-01806-1 · Cited by 504
Chahla, J., Cinque, M. E., Piuzzi, N. S., Mannava, S., Geeslin, A. G., Murray, I. R., Dornan, G. J., Muschler, G. F., & LaPrade, R. F. (2017) · Journal of Bone and Joint Surgery · doi:10.2106/jbjs.16.01374 · Cited by 504
The Microbiota–Gut–Brain Axis in Psychiatric Disorders
Góralczyk-Bińkowska, A., Szmajda-Krygier, D., & Kozłowska, E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911245 · Cited by 495
Targeting the IDO1/TDO2–KYN–AhR Pathway for Cancer Immunotherapy – Challenges and Opportunities
Cheong, J. E., & Sun, L. (2018) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2017.11.007 · Cited by 487
Brain-derived neurotrophic factor: a bridge between inflammation and neuroplasticity
Calabrese, F., Rossetti, A. C., Racagni, G., Gass, P., Riva, M. A., & Molteni, R. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00430 · Cited by 482
Nutritional psychiatry: The present state of the evidence
Marx, W., Moseley, G., Berk, M., & Jacka, F. (2017) · Proceedings of the Nutrition Society · doi:10.1017/s0029665117002026 · Cited by 469 · cited 1×
“Thus, combining dietary and pharmacological approaches is not merely additive but can produce synergistic effects, optimizing both symptom relief and overall health outcomes [389,403].”
Tryptophan Metabolic Pathways and Brain Serotonergic Activity: A Comparative Review
Höglund, E., Øverli, Ø., & Winberg, S. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00158 · Cited by 438
Adjunctive Nutraceuticals for Depression: A Systematic Review and Meta-Analyses
Sarris, J., Murphy, J., Mischoulon, D., Papakostas, G. I., Fava, M., Berk, M., & Ng, C. H. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2016.15091228 · Cited by 436 · cited 1×
“Nutrient-focused approaches, including supplementation with omega-3 fatty acids, vitamin D, and probiotics, have shown additive benefits, with effects on neurotransmitter synthesis, immune regulation, and gut–brain communication that complement pharmacological mechanisms [388,396,397].”
The NLRP3 inflammasome: Mechanism of action, role in disease and therapies
Wang, L., & Hauenstein, A. V. (2020) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2020.100889 · Cited by 426 · cited 1×
“Together, they build an inflammatory loop that shapes mood and cognition [60–62].”
Zagoskina, N. V., Zubova, M. Y., Nechaeva, T. L., Kazantseva, V. V., Goncharuk, E. A., Katanskaya, V. M., Baranova, E. N., & Aksenova, M. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241813874 · Cited by 423
The progress of gut microbiome research related to brain disorders
Zhu, S., Jiang, Y., Xu, K., Cui, M., Ye, W., Zhao, G., Jin, L., & Chen, X. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-1705-z · Cited by 419 · cited 2×
“The identity of key microbial species responsible for shaping Trp metabolism is incompletely defined, and the molecular mechanisms that orchestrate the balance be-tween the 5-HT, KYN, and indole pathways remain unclear [194,197,198].”
Microbiota-Gut-Brain Axis: New Therapeutic Opportunities
Long-Smith, C., O'Riordan, K. J., Clarke, G., Stanton, C., Dinan, T. G., & Cryan, J. F. (2020) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010919-023628 · Cited by 419
Labadie, B. W., Bao, R., & Luke, J. J. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-2882 · Cited by 413
Tartt, A. N., Mariani, M. B., Hen, R., Mann, J. J., & Boldrini, M. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01520-y · Cited by 408
Witcher, K. G., Bray, C. E., Chunchai, T., Zhao, F., O'Neil, S. M., Gordillo, A. J., Campbell, W. A., McKim, D. B., Liu, X., Dziabis, J. E., et al. (2021) · The Journal of Neuroscience · doi:10.1523/jneurosci.2469-20.2020 · Cited by 387 · cited 1×
“Sustained IL-10 exposure or traumatic injury reprograms microglia toward a phagocytic, synapse-stripping phenotype that disrupts neuron–glia crosstalk and shortens the lifespan of new-born neurons [100–102].”
Gut microbiota and major depressive disorder: a systematic review and meta-analysis
Sanada, K., Nakajima, S., Kurokawa, S., Barceló-Soler, A., Ikuse, D., Hirata, A., Yoshizawa, A., Tomizawa, Y., Salas-Valero, M., Noda, Y., et al. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.01.102 · Cited by 372
Association of the Eosinophilia–Myalgia Syndrome with the Ingestion of Tryptophan
Hertzman, P. A., Blevins, W. L., Mayer, J., Greenfield, B., Ting, M., & Gleich, G. J. (1990) · New England Journal of Medicine · doi:10.1056/nejm199003293221301 · Cited by 366
Deng, Y., Zhou, M., Wang, J., Yao, J., Yu, J., Liu, W., Wu, L., Wang, J., & Gao, R. (2021) · Gut Microbes · doi:10.1080/19490976.2020.1869501 · Cited by 362
Molecular adaptations of the blood–brain barrier promote stress resilience vs. depression
Dudek, K. A., Dion-Albert, L., Lebel, M., LeClair, K., Labrecque, S., Tuck, E., Ferrer Perez, C., Golden, S. A., Tamminga, C., Turecki, G., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1914655117 · Cited by 361 · cited 1×
“Together, the data suggest that berberine and albiflorin represent promising candidates for modulating Trp metabolism, suppressing neuroinflammation, and enhancing cognitive resilience, warranting rigorous clinical validation to confirm their therapeutic potential [279,280].”
Tian, P., Chen, Y., Zhu, H., Wang, L., Qian, X., Zou, R., Zhao, J., Zhang, H., Qian, L., Wang, Q., et al. (2022) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2021.11.023 · Cited by 356
Correia, A. S., & Vale, N. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158493 · Cited by 350
Correia, A. S., Cardoso, A., & Vale, N. (2023) · Antioxidants · doi:10.3390/antiox12020470 · Cited by 340
Benkelfat, C. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950090019003 · Cited by 336
How important is tryptophan in human health?
Kałużna-Czaplińska, J., Gątarek, P., Chirumbolo, S., Chartrand, M. S., & Bjørklund, G. (2019) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2017.1357534 · Cited by 333 · cited 6×
“Isolated supplementation offers clear pharmacological advantages, including predictable dosing, rapid absorption, and more consistent increases in serum Trp and downstream metabolites [301,303,304].”
InfluentialMarx, W., McGuinness, A. J., Rocks, T., Ruusunen, A., Cleminson, J., Walker, A. J., Gomes-da-Costa, S., Lane, M., Sanches, M., Diaz, A. P., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-020-00951-9 · Cited by 322
Indoleamine 2,3-dioxygenase (IDO) inhibitors and cancer immunotherapy
Fujiwara, Y., Kato, S., Nesline, M. K., Conroy, J. M., DePietro, P., Pabla, S., & Kurzrock, R. (2022) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2022.102461 · Cited by 304
Kynurenine pathway in depression: a systematic review and meta-analysis
Ogyu, K., Kubo, K., Noda, Y., Iwata, Y., Tsugawa, S., Omura, Y., Wada, M., Tarumi, R., Plitman, E., Moriguchi, S., et al. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.03.023 · Cited by 301
Markus, C. R., Olivier, B., Panhuysen, G. E., Van der Gugten, J., Alles, M. S., Tuiten, A., Westenberg, H. G., Fekkes, D., Koppeschaar, H. F., & de Haan, E. E. (2000) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/71.6.1536 · Cited by 296
NLRP3 inflammasome in neuroinflammation and central nervous system diseases
Xu, W., Huang, Y., & Zhou, R. (2025) · Cellular & Molecular Immunology · doi:10.1038/s41423-025-01275-w · Cited by 295
Tryptophan in health and disease
(2020) · Advances in Clinical Chemistry · doi:10.1016/bs.acc.2019.08.005 · Cited by 294
Plant-derived bioactive compounds in colon cancer treatment: An updated review
Esmeeta, A., Adhikary, S., Dharshnaa, V., Swarnamughi, P., Ummul Maqsummiya, Z., Banerjee, A., Pathak, S., & Duttaroy, A. K. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113384 · Cited by 293
Analysis, Nutrition, and Health Benefits of Tryptophan
Friedman, M. (2018) · International Journal of Tryptophan Research · doi:10.1177/1178646918802282 · Cited by 292
Mediterranean Diet as an Antioxidant: The Impact on Metabolic Health and Overall Wellbeing
Gantenbein, K. V., & Kanaka-Gantenbein, C. (2021) · Nutrients · doi:10.3390/nu13061951 · Cited by 288 · cited 1×
“Broader inclusion criteria have encompassed patients with MDD or bulimia, while preclinical successes with compounds like albiflorin highlight the translational potential awaiting human validation [219–221].”
IL4-driven microglia modulate stress resilience through BDNF-dependent neurogenesis
Zhang, J., Rong, P., Zhang, L., He, H., Zhou, T., Fan, Y., Mo, L., Zhao, Q., Han, Y., Li, S., et al. (2021) · Science Advances · doi:10.1126/sciadv.abb9888 · Cited by 287
Du Preez, A., Onorato, D., Eiben, I., Musaelyan, K., Egeland, M., Zunszain, P. A., Fernandes, C., Thuret, S., & Pariante, C. M. (2021) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.07.015 · Cited by 285
Tryptophan Metabolism as a Pharmacological Target
Modoux, M., Rolhion, N., Mani, S., & Sokol, H. (2021) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2020.11.006 · Cited by 284
Neuroplasticity as a convergent mechanism of ketamine and classical psychedelics
Aleksandrova, L. R., & Phillips, A. G. (2021) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2021.08.003 · Cited by 276
Polyphenols and Their Impact on the Prevention of Neurodegenerative Diseases and Development
Grabska-Kobyłecka, I., Szpakowski, P., Król, A., Książek-Winiarek, D., Kobyłecki, A., Głąbiński, A., & Nowak, D. (2023) · Nutrients · doi:10.3390/nu15153454 · Cited by 273
Han, Y., Wang, B., Gao, H., He, C., Hua, R., Liang, C., Zhang, S., Wang, Y., Xin, S., & Xu, J. (2022) · Journal of Inflammation Research · doi:10.2147/jir.s384949 · Cited by 265
Tryptophan and indole metabolism in immune regulation
Fiore, A., & Murray, P. J. (2021) · Current Opinion in Immunology · doi:10.1016/j.coi.2020.12.001 · Cited by 260
Effect of fecal microbiota transplant on symptoms of psychiatric disorders: a systematic review
Chinna Meyyappan, A., Forth, E., Wallace, C. J. K., & Milev, R. (2020) · BMC Psychiatry · doi:10.1186/s12888-020-02654-5 · Cited by 254
Tian, P., Wang, G., Zhao, J., Zhang, H., & Chen, W. (2019) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2019.01.007 · Cited by 251
Xiong, R.-G., Li, J., Cheng, J., Zhou, D.-D., Wu, S.-X., Huang, S.-Y., Saimaiti, A., Yang, Z.-J., Gan, R.-Y., & Li, H.-B. (2023) · Nutrients · doi:10.3390/nu15143258 · Cited by 249
Immune Influencers in Action: Metabolites and Enzymes of the Tryptophan-Kynurenine Metabolic Pathway
Tanaka, M., Tóth, F., Polyák, H., Szabó, Á., Mándi, Y., & Vécsei, L. (2021) · Biomedicines · doi:10.3390/biomedicines9070734 · Cited by 248
Self-citationZhou, M., Fan, Y., Xu, L., Yu, Z., Wang, S., Xu, H., Zhang, J., Zhang, L., Liu, W., Wu, L., et al. (2023) · Microbiome · doi:10.1186/s40168-023-01589-9 · Cited by 244
Tryptophan Dietary Impacts Gut Barrier and Metabolic Diseases
Taleb, S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02113 · Cited by 236 · cited 1×
“The resulting uncertainty complicates translation into clinical practice [195,308,309].”
Maffei, M. E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010181 · Cited by 236 · cited 6×
“The 5-HT pathway begins when Trp is hydroxylated by TPH1 and TPH2, producing 5-HTP, which is then decarboxylated to form 5-HT [141,142].”
InfluentialPharmacogenomics: Driving Personalized Medicine
Sadee, W., Wang, D., Hartmann, K., & Toland, A. E. (2023) · Pharmacological Reviews · doi:10.1124/pharmrev.122.000810 · Cited by 235
Pu, J., Liu, Y., Zhang, H., Tian, L., Gui, S., Yu, Y., Chen, X., Chen, Y., Yang, L., Ran, Y., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-020-0645-4 · Cited by 230
Modulation of neurotrophic signaling pathways by polyphenols
Firuzi, O., Moosavi, F., Hosseini, R., & Saso, L. (2015) · Drug Design, Development and Therapy · doi:10.2147/dddt.s96936 · Cited by 221
Zhang, K., Wang, F., Zhai, M., He, M., Hu, Y., Feng, L., Li, Y., Yang, J., & Wu, C. (2023) · Theranostics · doi:10.7150/thno.81067 · Cited by 217
Sarris, J., Ravindran, A., Yatham, L. N., Marx, W., Rucklidge, J. J., McIntyre, R. S., Akhondzadeh, S., Benedetti, F., Caneo, C., Cramer, H., et al. (2022) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2021.2013041 · Cited by 216
Role of IDO and TDO in Cancers and Related Diseases and the Therapeutic Implications
Ye, Z., Yue, L., Shi, J., Shao, M., & Wu, T. (2019) · Journal of Cancer · doi:10.7150/jca.31727 · Cited by 212
The role of the microbiota-gut-brain axis in neuropsychiatric disorders
Generoso, J. S., Giridharan, V. V., Lee, J., Macedo, D., & Barichello, T. (2021) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2020-0987 · Cited by 211
Kouba, B. R., de Araujo Borba, L., Borges de Souza, P., Gil-Mohapel, J., & Rodrigues, A. L. S. (2024) · Cells · doi:10.3390/cells13050423 · Cited by 209
Mechanisms of Short-Chain Fatty Acids Derived from Gut Microbiota in Alzheimer's Disease
Qian, X.-H., Xie, R.-Y., Liu, X.-L., Chen, S.-D., & Tang, H.-D. (2022) · Aging and disease · doi:10.14336/ad.2021.1215 · Cited by 208
Hestad, K., Alexander, J., Rootwelt, H., & Aaseth, J. O. (2022) · Biomolecules · doi:10.3390/biom12070998 · Cited by 200
Phan, M. A. T., Paterson, J., Bucknall, M., & Arcot, J. (2018) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2016.1254595 · Cited by 200
Bravo, R., Matito, S., Cubero, J., Paredes, S. D., Franco, L., Rivero, M., Rodríguez, A. B., & Barriga, C. (2013) · AGE · doi:10.1007/s11357-012-9419-5 · Cited by 199
Cheng, J., Hu, H., Ju, Y., Liu, J., Wang, M., Liu, B., & Zhang, Y. (2024) · General Psychiatry · doi:10.1136/gpsych-2023-101374 · Cited by 196
Amanollahi, M., Jameie, M., Heidari, A., & Rezaei, N. (2023) · Molecular Neurobiology · doi:10.1007/s12035-022-03102-z · Cited by 195
Proudman, D., Greenberg, P., & Nellesen, D. (2021) · PharmacoEconomics · doi:10.1007/s40273-021-01040-7 · Cited by 194
The Neuroprotective Potentiality of Flavonoids on Alzheimer’s Disease
Calderaro, A., Patanè, G. T., Tellone, E., Barreca, D., Ficarra, S., Misiti, F., & Laganà, G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232314835 · Cited by 194
Serotonin—Its Synthesis and Roles in the Healthy and the Critically Ill
Kanova, M., & Kohout, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094837 · Cited by 193
Lipopolysaccharide-induced depression-like model in mice: meta-analysis and systematic evaluation
Yin, R., Zhang, K., Li, Y., Tang, Z., Zheng, R., Ma, Y., Chen, Z., Lei, N., Xiong, L., Guo, P., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1181973 · Cited by 189
Salminen, A. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101573 · Cited by 188
Role of Kynurenine Pathway in Oxidative Stress during Neurodegenerative Disorders
Mor, A., Tankiewicz-Kwedlo, A., Krupa, A., & Pawlak, D. (2021) · Cells · doi:10.3390/cells10071603 · Cited by 187
Liang, H., Dai, Z., Kou, J., Sun, K., Chen, J., Yang, Y., Wu, G., & Wu, Z. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms20010020 · Cited by 186
Phytochemicals and cognitive health: Are flavonoids doing the trick?
Bakoyiannis, I., Daskalopoulou, A., Pergialiotis, V., & Perrea, D. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.10.086 · Cited by 185
Rahman, M. A., Hannan, M. A., Dash, R., Rahman, M. H., Islam, R., Uddin, M. J., Sohag, A. A. M., Rahman, M. H., & Rhim, H. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.639628 · Cited by 181
Lezoul, N. E. H., Belkadi, M., Habibi, F., & Guillén, F. (2020) · Molecules · doi:10.3390/molecules25204672 · Cited by 180
Laurindo, L. F., Dias, J. A., Araújo, A. C., Pomini, K. T., Galhardi, C. M., Detregiachi, C. R. P., Haber, L. S. D. A., Roque, D. D., Bechara, M. D., de Castro, M. V. M., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1305933 · Cited by 179
Self-citationEvidence of the Importance of Dietary Habits Regarding Depressive Symptoms and Depression
Ljungberg, T., Bondza, E., & Lethin, C. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17051616 · Cited by 179
Fujigaki, H., Yamamoto, Y., & Saito, K. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.01.011 · Cited by 178
The NLRP3 inflammasome in depression: Potential mechanisms and therapies
Xia, C.-Y., Guo, Y.-X., Lian, W.-W., Yan, Y., Ma, B.-Z., Cheng, Y.-C., Xu, J.-K., He, J., & Zhang, W.-K. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2022.106625 · Cited by 178
Thomson, J., Rankin, H., Ashcroft, G. W., Yates, C. M., McQueen, J. K., & Cummings, S. W. (1982) · Psychological Medicine · doi:10.1017/s0033291700049047 · Cited by 177
Rahbardar, M. G., & Hosseinzadeh, H. (2020) · PubMed · doi:10.22038/ijbms.2020.45269.10541 · Cited by 176
Understanding the Gut–Brain Axis and Its Therapeutic Implications for Neurodegenerative Disorders
Zheng, Y., Bonfili, L., Wei, T., & Eleuteri, A. M. (2023) · Nutrients · doi:10.3390/nu15214631 · Cited by 175
Biswas, K. (2023) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2023.578180 · Cited by 175
Zhang, J., He, H., Qiao, Y., Zhou, T., He, H., Yi, S., Zhang, L., Mo, L., Li, Y., Jiang, W., et al. (2020) · Glia · doi:10.1002/glia.23878 · Cited by 174 · cited 1×
“Seven-Tesla datasets pinpoint shrinkage to dentate gyrus and tail subfields, especially in treatment-resistant illness [89,91,92].”
The Role of Serotonin Neurotransmission in Gastrointestinal Tract and Pharmacotherapy
Guzel, T., & Mirowska-Guzel, D. (2022) · Molecules · doi:10.3390/molecules27051680 · Cited by 174
Tribulations and future opportunities for artificial intelligence in precision medicine
Carini, C., & Seyhan, A. A. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05067-0 · Cited by 173
Medicinal Plants Used for Anxiety, Depression, or Stress Treatment: An Update
Kenda, M., Glavač, N. K., Nagy, M., & Dolenc, M. S. (2022) · Molecules · doi:10.3390/molecules27186021 · Cited by 173
Personalized Nutrition: Tailoring Dietary Recommendations through Genetic Insights
Singar, S., Nagpal, R., Arjmandi, B. H., & Akhavan, N. S. (2024) · Nutrients · doi:10.3390/nu16162673 · Cited by 173
Ma, N., He, T., Johnston, L. J., & Ma, X. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1758008 · Cited by 169
Salminen, A. (2023) · Journal of Molecular Medicine · doi:10.1007/s00109-023-02289-5 · Cited by 168
Klawonn, A. M., Fritz, M., Castany, S., Pignatelli, M., Canal, C., Similä, F., Tejeda, H. A., Levinsson, J., Jaarola, M., Jakobsson, J., et al. (2021) · Immunity · doi:10.1016/j.immuni.2020.12.016 · Cited by 167
Hunt, C., Cordeiro, T. M. E., Suchting, R., de Dios, C., Cuellar, V. A., Soares, J. C., Dantzer, R., Teixeira, A. L., & Selvaraj, S. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.08.010 · Cited by 166
Wang, Y.-L., Wu, H., Zhang, S., Xiao, H., Yu, J. M., Ma, Y.-Y., Zhang, Y., & Liu, Q. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01468-7 · Cited by 166
Lasselin, J., Schedlowski, M., Karshikoff, B., Engler, H., Lekander, M., & Konsman, J. P. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.05.001 · Cited by 165 · cited 1×
“…these findings portray a feed-forward inflammatory circuit that not only marks depressive severity and chronicity but also delineates mechanistic targets for next-generation precision antidepressants, with potential for biomarker-guided stratification in clinical practice worldwide [72,73,78].”
Bain, E. E., Shafner, L., Walling, D. P., Othman, A. A., Chuang-Stein, C., Hinkle, J., & Hanina, A. (2017) · JMIR mHealth and uHealth · doi:10.2196/mhealth.7030 · Cited by 163
Qin, Z., Shi, D.-D., Li, W., Cheng, D., Zhang, Y.-D., Zhang, S., Tsoi, B., Zhao, J., Wang, Z., & Zhang, Z.-J. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02744-7 · Cited by 162
Jones, S. P., Franco, N. F., Varney, B., Sundaram, G., Brown, D. A., de Bie, J., Lim, C. K., Guillemin, G. J., & Brew, B. J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0131389 · Cited by 162
Major Depression: One Brain, One Disease, One Set of Intertwined Processes
Filatova, E. V., Shadrina, M. I., & Slominsky, P. A. (2021) · Cells · doi:10.3390/cells10061283 · Cited by 160
Donoso, F., Cryan, J. F., Olavarría‐Ramírez, L., Nolan, Y. M., & Clarke, G. A. (2022) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.2581 · Cited by 159
Fecal Microbiota Transplantation (FMT) as an Adjunctive Therapy for Depression—Case Report
Doll, J. P. K., Vázquez-Castellanos, J. F., Schaub, A.-C., Schweinfurth, N., Kettelhack, C., Schneider, E., Yamanbaeva, G., Mählmann, L., Brand, S., Beglinger, C., et al. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.815422 · Cited by 158
Toward a Deeper Understanding of Gut Microbiome in Depression: The Promise of Clinical Applicability
Liu, L., Wang, H., Zhang, H., Chen, X., Zhang, Y., Wu, J., Zhao, L., Wang, D., Pu, J., Ji, P., et al. (2022) · Advanced Science · doi:10.1002/advs.202203707 · Cited by 158
Does Study Design Influence Outcome?
Rutherford, B. R., Sneed, J. R., & Roose, S. P. (2009) · Psychotherapy and Psychosomatics · doi:10.1159/000209348 · Cited by 158
Li, Y., Peng, Y., Shen, Y., Zhang, Y., Liu, L., & Yang, X. (2023) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2076064 · Cited by 156 · cited 1×
“Evidence now en-dorses blended strategies that curb inflammation, recalibrate microbiota signaling, temper glutamatergic drive, and reignite neurogenesis [126,127].”
Chen, L., Liu, B., Ren, L., Du, H., Fei, C., Qian, C., Li, B., Zhang, R., Liu, H., Li, Z., et al. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1069954 · Cited by 155 · cited 1×
“Impor-tantly, precision nutrition also considers comorbidities: in patients with obesity or diabetes, individualized nutritional plans have demonstrated benefits not only for metabolic regulation but also for mood stabilization [265,428,430].”
The Clinical Spectrum of the Eosinophilia-Myalgia Syndrome Associated with L -Tryptophan Ingestion
Martin, R. W., Duffy, J., Engel, A. G., Lie, J. T., Bowles, C. A., Moyer, T. P., & Gleich, G. J. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-113-2-124 · Cited by 153
Winiarska‐Mieczan, A., Kwiecień, M., Jachimowicz-Rogowska, K., Donaldson, J., Tomaszewska, E., & Baranowska‐Wójcik, E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032258 · Cited by 152
Plant-Derived Nutraceuticals and Immune System Modulation: An Evidence-Based Overview
Sotto, A. D., Vitalone, A., & Giacomo, S. D. (2020) · Vaccines · doi:10.3390/vaccines8030468 · Cited by 152
Stress induced microglial activation contributes to depression
Li, B., Yang, W., Ge, T., Wang, Y., & Cui, R. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106145 · Cited by 151
Microbiota–neuroepithelial signalling across the gut–brain axis
Ohara, T. E., & Hsiao, E. Y. (2025) · Nature Reviews Microbiology · doi:10.1038/s41579-024-01136-9 · Cited by 147
Adherence to the Mediterranean Diet is Associated with Better Sleep Quality in Italian Adults
Godos, J., Ferri, R., Caraci, F., Cosentino, F. I. I., Castellano, S., Galvano, F., & Grosso, G. (2019) · Nutrients · doi:10.3390/nu11050976 · Cited by 145 · cited 1×
“Standard outcome measures include psychiatric rating scales, sleep quality indices, and neurochemical assays, allowing assessment of both symptomatic relief and mechanistic engagement [220,222,223].”
Neuroprotective Properties of Berberine: Molecular Mechanisms and Clinical Implications
Tian, E., Sharma, G., & Dai, C. (2023) · Antioxidants · doi:10.3390/antiox12101883 · Cited by 144
Bolton, J. L., Short, A. K., Othy, S., Kooiker, C. L., Shao, M., Gunn, B. G., Beck, J., Bai, X., Law, S. M., Savage, J. C., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110600 · Cited by 143
Abbaszadeh, F., Fakhri, S., & Khan, H. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105069 · Cited by 141
Sharifi, S., Mahmoud, N. N., Voke, E., Landry, M. P., & Mahmoudi, M. (2022) · Nano-Micro Letters · doi:10.1007/s40820-022-00922-5 · Cited by 141
Role of the intestinal microbiome, intestinal barrier and psychobiotics in depression
Trzeciak, P., & Herbet, M. (2021) · Nutrients · doi:10.3390/nu13030927 · Cited by 139
Zhang, Z.-W., Gao, C.-S., Zhang, H., Yang, J., Wang, Y.-P., Pan, L.-B., Yu, H., He, C.-Y., Luo, H.-B., Zhao, Z.-X., et al. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.02.032 · Cited by 139
Mediterranean Diet on Sleep: A Health Alliance
Scoditti, E., Tumolo, M. R., & Garbarino, S. (2022) · Nutrients · doi:10.3390/nu14142998 · Cited by 138
Huang, Y., Zhao, M., Chen, X., Zhang, R., Le, A., Hong, M., Zhang, Y., Jia, L., Zang, W., Jiang, C., et al. (2023) · Aging and disease · doi:10.14336/ad.2022.0916 · Cited by 138 · cited 10×
“The problem deepens when pro-inflammatory cytokines activate indoleamine 2,3-dioxygenases (IDOs), shunting Trp down the KYN track, exhausting 5-HT, and generating neurotoxic QA [10,13].”
InfluentialDepression: Biological markers and treatment
Erjavec, G. N., Šagud, M., Perković, M. N., Štrac, D. Š., Konjevod, M., Tudor, L., Uzun, S., & Pivac, N. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110139 · Cited by 136
Nematolahi, P., Mehrabani, M., Karami‐Mohajeri, S., & Dabaghzadeh, F. (2017) · Complementary Therapies in Clinical Practice · doi:10.1016/j.ctcp.2017.11.004 · Cited by 136
Natural products, micronutrients, and nutraceuticals for the treatment of depression: A short review
Nabavi, S. M., Daglia, M., Braidy, N., & Nabavi, S. F. (2015) · Nutritional Neuroscience · doi:10.1080/1028415x.2015.1103461 · Cited by 136
Schefft, C., Kilarski, L. L., Bschor, T., & Köhler, S. (2017) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2017.07.004 · Cited by 135
Gabriel, F. C., de Melo, D. O., Fráguas, R., Leite-Santos, N. C., Silva, R. A. M., & Ribeiro, E. (2020) · PLoS ONE · doi:10.1371/journal.pone.0231700 · Cited by 135
The gut microbiota–brain axis in neurological disorders
You, M., Chen, N., Yang, Y., Cheng, L., He, H., Cai, Y., Liu, Y., Liu, H., & Hong, G. (2024) · MedComm · doi:10.1002/mco2.656 · Cited by 132
Tryptophan metabolites in depression: Modulation by gut microbiota
Lukić, I., Ivković, S., Mitić, M., & Adžić, M. (2022) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2022.987697 · Cited by 131
Opie, R. S., O'Neil, A., Jacka, F. N., Pizzinga, J., & Itsiopoulos, C. (2018) · Nutritional Neuroscience · doi:10.1080/1028415x.2017.1312841 · Cited by 130
Tryptophan metabolism: Mechanism-oriented therapy for neurological and psychiatric disorders
Li, D., Yu, S., Long, Y., Shi, A., Deng, J., Ma, Y., Wen, J., Li, X., Liu, S., Zhang, Y., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.985378 · Cited by 129 · cited 2×
“While early-phase studies and small-scale trials suggest therapeutic promise, their limited sample sizes, short durations, and restricted demographic scope constrain clinical interpretation [115,354,355].”
Cui, Y., Cao, K., Lin, H., Cui, S., Shen, C., Wen, W., Mo, H., Dong, Z., Bai, S., Yang, L., et al. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00102 · Cited by 128
Cattaneo, A., Ferrari, C., Turner, L., Mariani, N., Enache, D., Hastings, C. N. M., Kose, M., Lombardo, G., McLaughlin, A. P., Nettis, M. A., et al. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-00874-7 · Cited by 128
Carniel, B. P., & da Rocha, N. S. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110151 · Cited by 127
Wang, D., Wu, J., Zhu, P., Xie, H., Lu, L., Bai, W., Pan, W., Shi, R., Ye, J., Xia, B., et al. (2022) · Food Research International · doi:10.1016/j.foodres.2022.111289 · Cited by 126
Gut-brain axis metabolic pathway regulates antidepressant efficacy of albiflorin
Zhao, Z., Fu, J., Ma, S., Peng, R., Yu, J., Lin, C., Pan, L., Zhang, Z., Tian, H., Che, C., et al. (2018) · Theranostics · doi:10.7150/thno.28068 · Cited by 125
Hu, B., Das, P., Lv, X., Shi, M., Aa, J., Wang, K., Duan, L., Gilbert, J. A., Nie, Y., & Wu, X. (2022) · mSystems · doi:10.1128/msystems.00218-22 · Cited by 124
Amino Acid Trp: The Far Out Impacts of Host and Commensal Tryptophan Metabolism
Grifka‐Walk, H. M., Jenkins, B. R., & Kominsky, D. J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.653208 · Cited by 122
Tryptophan and its metabolites in normal physiology and cancer etiology
Perez‐Castro, L., Garcia, R., Venkateswaran, N., Barnes, S. D., & Conacci‐Sorrell, M. (2021) · FEBS Journal · doi:10.1111/febs.16245 · Cited by 122
Athira, K. V., Bandopadhyay, S., Samudrala, P. K., Naidu, V. G. M., Lahkar, M., & Chakravarty, S. (2019) · Current Neuropharmacology · doi:10.2174/1570159x17666191001142934 · Cited by 117
Steinkamp, J., Goldblatt, N. P., Borodovsky, J. T., LaVertu, A. E., Kronish, I. M., Marsch, L. A., & Schuman‐Olivier, Z. (2018) · JMIR Mental Health · doi:10.2196/12493 · Cited by 116
Picard, K., Bisht, K., Poggini, S., Garofalo, S., Golia, M. T., Basilico, B., Abdallah, F., Albanese, N. C., Amrein, I., Vernoux, N., et al. (2021) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2021.07.022 · Cited by 116
Effects and Side Effects Associated with the Non-Nutritional Use of Tryptophan by Humans
Fernstrom, J. D. (2012) · Journal of Nutrition · doi:10.3945/jn.111.157065 · Cited by 116
L-tryptophan and eosinophilia-myalgia syndrome in New Mexico
Eidson, M., Sewell, C. M., Voorhees, R. E., Philen, R. M., & Kilbourne, E. M. (1990) · The Lancet · doi:10.1016/0140-6736(90)90421-z · Cited by 115
Tryptophan and 5-Hydroxytryptophan for depression
Shaw, K. A.-M., Turner, J., & Mar, C. D. (2002) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003198 · Cited by 115
Kynurenine Pathway in Diabetes Mellitus—Novel Pharmacological Target?
Kozieł, K., & Urbańska, E. M. (2023) · Cells · doi:10.3390/cells12030460 · Cited by 111
Tryptophan supplementation and serotonin function: genetic variations in behavioural effects
Gibson, E. L. (2018) · Proceedings of The Nutrition Society · doi:10.1017/s0029665117004451 · Cited by 111
Are Kynurenines Accomplices or Principal Villains in Dementia? Maintenance of Kynurenine Metabolism
Tanaka, M., Bohár, Z., & Vécsei, L. (2020) · Molecules · doi:10.3390/molecules25030564 · Cited by 110
Self-citationZhao, Z., Wang, Y., Zhou, R., Li, Y., Gao, Y., Tu, D., Wilson, B., Song, S., Feng, J., Hong, J.-S., et al. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-1728-5 · Cited by 109
Neuroimmune crosstalk in chronic neuroinflammation: microglial interactions and immune modulation
Müller, L., & Benedetto, S. D. (2025) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2025.1575022 · Cited by 109
Asad, A., Kirk, M., Zhu, S., Dong, X. Z., & Gao, M. (2024) · Nutrition Reviews · doi:10.1093/nutrit/nuae177 · Cited by 109
Martínez-Rodríguez, A., Rubio‐Arias, J. Á., Ramos‐Campo, D. J., Reche-García, C., Leyva-Vela, B., & Nadal-Nicolás, Y. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17072227 · Cited by 108
Skorobogatov, K., De Picker, L., Verkerk, R., Coppens, V., Leboyer, M., Müller, N., & Morrens, M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.716980 · Cited by 107
Cytokines and tryptophan metabolites can predict depressive symptoms in pregnancy
Sha, Q., Madaj, Z. B., Keaton, S. A., Galvis, M. L. E., Smart, L., Krzyżanowski, S., Fazleabas, A. T., Leach, R. E., Postolache, T. T., Achtyes, E. D., et al. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-01801-8 · Cited by 107
Ng, Q. X., Lim, Y. L., Yaow, C. Y. L., Ng, W., Thumboo, J., & Liew, T. M. (2023) · Nutrients · doi:10.3390/nu15061351 · Cited by 106
The kynurenine pathway in chronic diseases: a compensatory mechanism or a driving force?
Joisten, N., Ruas, J. L., Braidy, N., Guillemin, G. J., & Zimmer, P. (2021) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2021.07.006 · Cited by 106
Messaoud, A., Mensi, R., Douki, W., Neffati, F., Najjar, M. F., Gobbi, G., Valtorta, F., Gaha, L., & Comai, S. (2018) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2018.1468031 · Cited by 105
Tang, C., Wang, C., Wang, J., Wang, Q., Li, S., Wang, H., Zhou, F., & Li, J. (2022) · Nutrients · doi:10.3390/nu14091882 · Cited by 105
Shi, J., Du, P., Xie, Q., Wang, N., Li, H., Smith, E. E., Li, C., Liu, F., Huo, G., & Li, B. (2020) · Food & Function · doi:10.1039/d0fo02622k · Cited by 104
Rao, J., Xie, R., Li, L., Jiang, J. H., Du, L., Zeng, X., Li, G., Wang, C., & Qiao, Y. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.15192 · Cited by 103
Memory Enhancement with Kynurenic Acid and Its Mechanisms in Neurotransmission
Martos, D., Tuka, B., Tanaka, M., Vécsei, L., & Telegdy, G. (2022) · Biomedicines · doi:10.3390/biomedicines10040849 · Cited by 102
Self-citationSwainson, J., Reeson, M., Malik, U., Stefanuk, I., Cummins, M., & Sivapalan, S. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2023.01.094 · Cited by 102
Sutanto, C. N., Loh, W. W., & Kim, J. E. (2021) · Nutrition Reviews · doi:10.1093/nutrit/nuab027 · Cited by 102
Rondanelli, M., Opizzi, A., Faliva, M. A., Mozzoni, M., Antoniello, N., Cazzola, R., Savarè, R., Cerutti, R., Grossi, E., & Cestaro, B. (2012) · Nutritional Neuroscience · doi:10.1179/1476830511y.0000000032 · Cited by 101
Caballero-Gallardo, K., Quintero-Rincón, P., & Olivero‐Verbel, J. (2025) · Plants · doi:10.3390/plants14030400 · Cited by 101
A systematic review of the effect of L-tryptophan supplementation on mood and emotional functioning
Kikuchi, A. M., Tanabe, A., & Iwahori, Y. (2020) · Journal of Dietary Supplements · doi:10.1080/19390211.2020.1746725 · Cited by 100
Gut microbiota, kynurenine pathway and mental disorders – Review
Więdłocha, M., Marcinowicz, P., Janoska-Jaździk, M., & Szulc, A. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110145 · Cited by 99
Tomaz, V. D. S., Filho, A. J. M. C., Cordeiro, R. C., Jucá, P. M., Soares, M. V. R., Barroso, P. N., Cristino, L. M. F., Jiang, W., Teixeira, A. L., de Lucena, D. F., et al. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.03.022 · Cited by 98
Lieberman, H. R., Agarwal, S., & Fulgoni, V. L. I. (2016) · Journal of Nutrition · doi:10.3945/jn.115.226969 · Cited by 98
A critical moment in machine learning in medicine: on reproducible and interpretable learning
Ciobanu-Caraus, O., Aicher, A., Kernbach, J. M., Regli, L., Serra, C., & Staartjes, V. E. (2024) · Acta Neurochirurgica · doi:10.1007/s00701-024-05892-8 · Cited by 97
Tayab, M. A., Islam, M. N., Chowdhury, K. A. A., & Tasnim, F. M. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112668 · Cited by 96
Roles of microglia in adult hippocampal neurogenesis in depression and their therapeutics
Fang, S., Wu, Z., Guo, Y., Zhu, W., Wan, C., Yuan, N., Chen, J., Hao, W., Mo, X., Guo, X., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1193053 · Cited by 96
Markus, C. R., Firk, C., Gerhardt, C., Kloek, J., & Smolders, G. F. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1254-0 · Cited by 96
Prebiotic and Probiotic Modulation of the Microbiota–Gut–Brain Axis in Depression
Radford-Smith, D. E., & Anthony, D. C. (2023) · Nutrients · doi:10.3390/nu15081880 · Cited by 96
de Lima, E. P., Laurindo, L. F., Catharin, V. C. S., Direito, R., Tanaka, M., Jasmin Santos German, I., Lamas, C. B., Guiguer, E. L., Araújo, A. C., Fiorini, A. M. R., et al. (2025) · Metabolites · doi:10.3390/metabo15020124 · Cited by 94
Self-citation
Research works printed but not linked: 2
- Ribas, 2021, The different roles of Griffonia simplicifolia in the treatment of depression: A narrative review, Int. J. Complement. Alt. Med., 14, 167
- Moosavi, 2016, Modulation of neurotrophic signaling pathways by polyphenols, Drug Des. Devel Ther., 10, 23
Cited by
Tanaka, M., Araujo, A. C., Valenti, V. E., Guiguer, E. L., Catharin, V. C. S., Gualhardi, C. M., de Souza Bastos Mazuqueli Pereira, E., de Alvares Goulart, R., de Argolo Haber, R. S., de Carvalho, A. C. A., et al. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27052370 · Cited by 13
Self-citationJuhász, L., Galla, Z., Tanaka, M., & Vécsei, L. (2026) · Antioxidants · doi:10.3390/antiox15020261 · Cited by 10
Self-citationRammal, H., Noonan, A. M., Rivas, D., Sibai, D. S., Marcangeli, V., & Duque, G. (2026) · Biochimie · doi:10.1016/j.biochi.2026.02.016 · Cited by 2
Wang, X., Piao, Y., Xia, B., Chu, W., Yao, X., & Li, W. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2026.1834069 · Cited by 1
Tanaka, M., & Vécsei, L. (2026) · EXCLI journal · doi:10.17179/excli2026-9522 · Cited by 3
Self-citation
Metadata
- Authors
- Chehadi, A. C., Pereira de Lima, E., Detregiachi, C. R. P., Santos de Argollo Haber, R., Catharin, V. M. C. S., Fornari Laurindo, L., Engracia Valenti, V., Machado Galhardi, C., Tanaka, M., & Maria Barbalho, S.
- Affiliations
- Universidade de Marília (BR)
- Department of Biochemistry and Pharmacology, School of Medicine, Universidade de Marília (UNIMAR), Marília 17525-902, SP, Brazil
- Graduate Program in Structural and Functional Interactions in Rehabilitation, School of Medicine, Universidade de Marília (UNIMAR), Marília 17525-902, SP, Brazil
- Division of Cellular Growth, Hemodynamic and Homeostasis Disorders, Graduate Program in Medical Sciences, Faculdade de Medicina, Universidade de São Paulo (USP), São Paulo 01246-903, SP, Brazil
- Department of Cardiovascular and Metabolic Health, School of Philosophy and Sciences, Universidade Estadual Paulista (UNESP), Marília 17525-900, SP, Brazil
- University of Szeged (HU)
- Corresponding author
- Tanaka, Masaru
- ORCID
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2026-01-01
- Volume
- 27
- Issue
- 1
- Pages
- 465
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC12787022
- OpenAlex
- W7118002548
- Cited by
- 8
- References
- 431
- Citations by year
- 2026: 8
- FWCI
- 5.26
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- Preprints.org (acceptedVersion, cc-by)
- PubMed (publishedVersion)
- PubMed Central (publishedVersion, cc-by)
- Funders
- HUN-REN Hungarian Research Network
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Complementary and alternative medicine › Medicinal Plant Extracts Effects
- Keywords
- tryptophan metabolism, major depressive disorder, 5-hydroxytryptophan, isoflavones, berberine, polyphenols, phytochemicals, kynurenine pathway, gut-brain-immune axis, inflammation, neuroplasticity, anxiety, sleep regulation, cognitive function, precision psychiatry, dietary intervention
- MeSH terms
- Animals, Antidepressive Agents, Depression, Major Depressive Disorder, Depressive Disorder, Major, Diet, Humans, Neurobiology, Tryptophan
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.